PARPharmaceuticals

Par Technology CorporationProfit & Loss Statement

78.58
-7.53%

Par Technology Corporation Profit & Loss Statement (Annual)

Metric20252024202420232023
Tax Effect Of Unusual Items0.00-0.03 Cr0.000.19 Cr0.04 Cr
Tax Rate For Calcs0.250.050.260.210.25
Normalized EBITDA21.65 Cr-4.11 Cr23.06 Cr-5.49 Cr18.15 Cr
Total Unusual Items0.00-0.55 Cr0.000.91 Cr0.17 Cr
Total Unusual Items Excluding Goodwill0.00-0.55 Cr0.000.91 Cr0.17 Cr
Net Income From Continuing Operation Net Minority Interest13.36 Cr-8.99 Cr14.50 Cr-8.16 Cr11.33 Cr
Reconciled Depreciation3.65 Cr3.79 Cr3.44 Cr2.70 Cr3.23 Cr
Reconciled Cost Of Revenue38.13 Cr17.44 Cr33.79 Cr16.21 Cr66.40 Cr
EBITDA21.65 Cr-4.66 Cr23.06 Cr-4.58 Cr18.31 Cr
EBIT18.00 Cr-8.45 Cr19.62 Cr-7.28 Cr15.08 Cr
Net Interest Income-0.08 Cr-1.02 Cr-0.11 Cr-0.69 Cr-0.06 Cr
Interest Expense0.08 Cr1.02 Cr0.11 Cr0.69 Cr24000.00
Normalized Income13.36 Cr-8.47 Cr14.50 Cr-8.88 Cr11.21 Cr
Net Income From Continuing And Discontinued Operation13.36 Cr-0.50 Cr14.50 Cr-6.98 Cr11.33 Cr
Total Expenses85.12 Cr43.02 Cr76.26 Cr35.81 Cr80.54 Cr
Diluted Average Shares1.23 Cr3.42 Cr1.23 Cr2.76 Cr1.23 Cr
Basic Average Shares1.23 Cr3.42 Cr1.23 Cr2.76 Cr1.23 Cr
Diluted EPS10.86-0.1411.78-2.539.21
Basic EPS10.86-0.1411.78-2.539.21
Diluted NI Availto Com Stockholders13.36 Cr-0.50 Cr14.50 Cr-6.98 Cr11.33 Cr
Net Income Common Stockholders13.36 Cr-0.50 Cr14.50 Cr-6.98 Cr11.33 Cr
Otherunder Preferred Stock Dividend0.000.000.00
Net Income13.36 Cr-0.50 Cr14.50 Cr-6.98 Cr11.33 Cr
Net Income Including Noncontrolling Interests13.36 Cr-0.50 Cr14.50 Cr-6.98 Cr11.33 Cr
Net Income Discontinuous Operations0.008.49 Cr0.001.19 Cr0.00
Net Income Continuous Operations13.36 Cr-8.99 Cr14.50 Cr-8.16 Cr11.33 Cr
Tax Provision4.57 Cr-0.48 Cr5.02 Cr0.18 Cr3.75 Cr
Pretax Income17.92 Cr-9.47 Cr19.52 Cr-7.98 Cr15.08 Cr
Other Non Operating Income Expenses2.15 Cr0.11 Cr0.24 Cr-0.05 Cr0.24 Cr
Special Income Charges0.00-0.55 Cr0.000.91 Cr0.17 Cr
Net Non Operating Interest Income Expense-0.08 Cr-1.02 Cr-0.11 Cr-0.69 Cr-0.06 Cr
Interest Expense Non Operating0.08 Cr1.02 Cr0.11 Cr0.69 Cr24000.00
Operating Income15.85 Cr-8.02 Cr19.38 Cr-8.14 Cr14.56 Cr
Operating Expense46.99 Cr22.63 Cr42.47 Cr17.09 Cr14.13 Cr
Other Operating Expenses37.49 Cr33.53 Cr0.14 Cr
Depreciation And Amortization In Income Statement3.65 Cr0.85 Cr3.44 Cr0.19 Cr3.23 Cr
Depreciation Income Statement3.65 Cr3.44 Cr3.23 Cr
Gross Profit62.84 Cr14.61 Cr61.85 Cr8.94 Cr28.69 Cr
Cost Of Revenue38.13 Cr20.39 Cr33.79 Cr18.73 Cr66.40 Cr
Total Revenue100.97 Cr35.00 Cr95.64 Cr27.67 Cr95.10 Cr
Operating Revenue100.97 Cr35.00 Cr95.64 Cr27.67 Cr95.10 Cr
Total Operating Income As Reported-7.91 Cr-7.17 Cr
Other Income Expense-0.43 Cr0.86 Cr
Other Special Charges0.61 Cr-82000.000.01 Cr-0.17 Cr
Restructuring And Mergern Acquisition-0.06 Cr-0.92 Cr
Depreciation Amortization Depletion Income Statement0.85 Cr0.19 Cr
Amortization0.85 Cr0.19 Cr
Amortization Of Intangibles Income Statement0.85 Cr0.19 Cr
Research And Development6.73 Cr5.84 Cr
Selling General And Administration15.06 Cr7.02 Cr11.07 Cr6.00 Cr
Selling And Marketing Expense4.17 Cr5.38 Cr3.85 Cr4.76 Cr
General And Administrative Expense10.89 Cr1.64 Cr7.21 Cr1.24 Cr
Other Gand A10.89 Cr7.21 Cr
Interest Income0.23 Cr0.07 Cr
Rent Expense Supplemental0.13 Cr0.07 Cr
Write Off1.12 Cr0.00
Total Other Finance Cost0.11 Cr0.13 Cr
Interest Income Non Operating0.23 Cr0.07 Cr
Rent And Landing Fees0.13 Cr0.07 Cr

All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.